remdesivir

[ad_1] The United States Food and Drug Administration has authorized Gilead Sciences for the emergency use of its experimental remdesivir of antiviral drugs to treat patients with Covid-19. During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O’Day called the move an important first step, saying the company was … Read more